On #WorldBDDay 2022, we join with ~120 other organizations — working together to raise awareness about birth defects.
- 1 in every 33 babies is born with a birth defect.
- Our ReproAnswer System provides expert teratogen information to aid in decisions that help reduce that risk.
RightAnswer.com, Inc. is excited to announce the launch of the new ReproAnswer™ System, which enables healthcare providers to more effectively counsel pregnant patients about possible effects of prescription and over-the-counter medications on their developing babies. This information is critical to all women of child-bearing age – before, during, and after pregnancy and lactation.
RightAnswer developed the ReproAnswer System with SBIR (Small Business Innovation Research) grants sponsored by the Centers for Disease Control and Prevention (CDC). The CDC supports health promotion and disease prevention programs, and the SBIR grants help U.S. small businesses complete the R&D behind new products and technologies.
The ReproAnswer System bridges the gap between healthcare providers and needed information. Putting this comprehensive, curated, and targeted teratology information into the hands of healthcare providers will allow them to:
Exploring the Design and Role of Mobile Apps for Healthcare Providers to Find Teratogenic Information
American Medical Informatics Association® (AMIA) — Abstract
Healthcare providers (HCPs) caring for pregnant patients often need information on drug risks to the embryo or fetus, but such complex information takes time to find and is difficult to convey on an app. In this work, we first surveyed 167 HCPs to understand their current teratogen information-seeking practices to help inform our general design goals. Using the insights gained, we then designed a prototype of a mobile app and tested it with 22 HCPs. We learned that HCP’s information needs in this context can be grouped into 3 types: to understand, to decide, and to explain. Different sets of information and features may be needed to support these different needs. Further, while some HCPs had concerns about appearing unprofessional and unknowledgeable when using the app in front of patients, many did not. They noted that incorporating mobile information apps into practice improves information access, can help signal care and technology-savviness, in addition to providing an opportunity to engage and educate patients. Implications for design and additional features for reference apps for HCPs are discussed.